Nanobiotix S.A. - Common Stock (NBTX)

CUSIP: 63009J107

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock
Shares outstanding
46,821,220
Total 13F shares
5,645,042
Share change
-116,239
Total reported value
$25,554,914
Price per share
$4.73
Number of holders
8
Value change
-$414,807
Number of buys
3
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 63009J107?
CUSIP 63009J107 identifies NBTX - Nanobiotix S.A. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NBTX - Nanobiotix S.A. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
JOHNSON & JOHNSON
13F
Company
12%
5,623,816
$20,133,261 31 Mar 2025
13F
Invus Global Management, LLC
13D/G
Invus Public Equities, L.P.
8.9%
4,232,829
$13,545,053 $0 31 Dec 2023
BAILLIE GIFFORD & CO
13D/G
4.1%
1,919,670
$6,142,944 $0 31 Dec 2024
PERCEPTIVE ADVISORS LLC
13F
Company
0.22%
105,053
$376,090 31 Mar 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.02%
11,387
$40,765 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.02%
10,184
$36,051 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
0.01%
6,100
$21,838 31 Mar 2025
13F
UBS Group AG
13F
Company
0.01%
3,000
$10,740 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
706
$2,528 31 Mar 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
661
$2,340 31 Mar 2025
13F
CITIGROUP INC
13F
Company
0%
241
$853 31 Mar 2025
13F
RHUMBLINE ADVISERS
13F
Company
0%
33
$116 31 Mar 2025
13F
BARCLAYS PLC
13F
Company
0%
4
$14 31 Mar 2025
13F

Institutional Holders of Nanobiotix S.A. - Common Stock (NBTX) as of Q2 2025

As of 30 Jun 2025, Nanobiotix S.A. - Common Stock (NBTX) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,645,042 shares. The largest 9 holders included JOHNSON & JOHNSON, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, UBS Group AG, BNP PARIBAS FINANCIAL MARKETS, EverSource Wealth Advisors, LLC, RHUMBLINE ADVISERS, NATIONAL BANK OF CANADA /FI/, and BARCLAYS PLC. This page lists 9 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
10
Q2 2025 holders
8
Holder diff
-2
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .